III型前胶原N端前肽评估的胶原形成是可遗传特征,并与磁共振弹性成像评估的肝纤维化相关
该横断面分析纳入306名参与者(含NAFLD肝硬化先证者及其一级亲属、无进展纤维化NAFLD先证者及其亲属、无NAFLD对照及其亲属),发现血清PRO-C3与磁共振弹性成像评估的肝纤维化强相关(r²=0.50,P<0.001),且具有稳健的遗传力(h²=0.36,95%CI 0.07-0.59,P=0.016)。PRO-C3与脂肪变性存在强遗传相关,与纤维化存在强环境相关;TM6SF2 rs58542926-T等位基因携带者PRO-C3浓度更高。
要点
- 血清PRO-C3与磁共振弹性成像评估的肝纤维化强相关(r²=0.50,P<0.001)。
- PRO-C3浓度具有稳健的遗传力(h²=0.36,95%CI 0.07-0.59,P=0.016)。
- TM6SF2 rs58542926-T携带者PRO-C3浓度高于非携带者(15.7±10.5 vs 10.8±5.7 ng/L,P=0.047)。
核心结论
- 血清PRO-C3与磁共振弹性成像评估的纤维化相关,具有可遗传性,与肝脂肪变性共享遗传相关,与肝纤维化共享环境相关。
- PRO-C3浓度似乎与纤维化和脂肪变性均有关联,并在TM6SF2 rs58542926风险等位基因携带者中升高。
研究设计与样本
- 对306名参与者的特征明确的前瞻性队列进行横断面分析,包括44名NAFLD肝硬化先证者及其72名一级亲属、24名无进展纤维化NAFLD先证者及其24名一级亲属、72名无NAFLD对照及其72名一级亲属。
- 肝脂肪变性通过磁共振成像质子密度脂肪分数评估,肝纤维化通过磁共振弹性成像测量的硬度评估,血清PRO-C3通过竞争性酶联免疫吸附测定评估。
- 评估了PRO-C3浓度的家族相关性、PRO-C3浓度与肝脂肪变性和纤维化之间的共享基因效应,以及PRO-C3浓度与PNPLA3、TM6SF2、MBOAT和CGKR基因遗传变异之间的关联。
主要发现
- 在包括年龄、性别、体重指数和族裔的多变量校正模型中,血清PRO-C3与肝纤维化强相关(r²=0.50,P<0.001)。
- PRO-C3浓度表现出稳健的遗传力(h²=0.36;95%CI 0.07-0.59;P=0.016)。
- PRO-C3浓度与脂肪变性存在强遗传相关(共享遗传决定度:0.62;95%CI 0.236-1.001;P=0.002)。
- PRO-C3浓度与纤维化存在强环境相关(共享环境决定度:0.55;95%CI 0.317-0.717;P<0.001)。
- TM6SF2 rs58542926-T等位基因携带者的PRO-C3浓度高于非携带者:15.7±10.5 vs 10.8±5.7 ng/L(P=0.047)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
N-terminal propeptide of type 3 procollagen (PRO-C3) is a biomarker of liver fibrosis in nonalcoholic fatty liver disease (NAFLD). This study examines the association between PRO-C3 concentration and liver fibrosis assessed by magnetic resonance elastography (MRE)-measured stiffness (MRE-stiffness) and the heritability of PRO-C3 concentration in a cohort of twins and families with and without NAFLD. We performed a cross-sectional analysis of a well-characterized prospective cohort of 306 participants, including 44 probands with NAFLD-cirrhosis and their 72 first-degree relatives, 24 probands with NAFLD without advanced fibrosis and their 24 first-degree relatives, and 72 controls without NAFLD and their 72 first-degree relatives. Liver steatosis was assessed by magnetic resonance imaging proton density fat fraction, and liver fibrosis was assessed by MRE-stiffness. Serum PRO-C3 was assessed by competitive, enzyme-linked immunosorbent assay. We assessed the familial correlation of PRO-C3 concentration, the shared gene effects between PRO-C3 concentration and liver steatosis and fibrosis, and the association between PRO-C3 concentration and genetic variants in the patatin-like phospholipase domain-containing 3 (PNPLA3), transmembrane 6 superfamily member 2 (TM6SF2), membrane-bound O-acyltransferase domain-containing (MBOAT), and glucokinase regulator (CGKR) genes. In multivariable-adjusted models including age, sex, body mass index, and ethnicity, serum PRO-C3 correlated strongly with liver fibrosis (r2 = 0.50, P < 0.001) and demonstrated robust heritability (h2 , 0.36; 95% confidence interval [CI], 0.07, 0.59; P = 0.016). PRO-C3 concentration and steatosis had a strong genetic correlation (shared genetic determination: 0.62; 95% CI, 0.236, 1.001; P = 0.002), whereas PRO-C3 concentration and fibrosis had a strong environmental correlation (shared environmental determination: 0.55; 95% CI, 0.317, 0.717; P < 0.001). PRO-C3 concentrations were higher in carriers of the TM6SF2 rs58542926-T allele compared with noncarriers: 15.7 (± 10.5) versus 10.8 (± 5.7) ng/L (P = 0.047). Conclusion: Serum PRO-C3 correlates with MRE-assessed fibrosis, is heritable, shares genetic correlation with liver steatosis and shares environmental correlation with liver fibrosis. PRO-C3 concentration appears to be linked to both fibrosis and steatosis and increased in carriers of the TM6SF2 rs58542926 risk allele.
引用
- Caussy C, Bhargava M, Villesen IF, et al. Collagen Formation Assessed by N-Terminal Propeptide of Type 3 Procollagen Is a Heritable Trait and Is Associated With Liver Fibrosis Assessed by Magnetic Resonance Elastography. Hepatology. 2019. PMID: 30859582. doi:10.1002/hep.30610
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。